Chemed - CHE Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings or view top-rated stocks.

1 brokers have issued 1 year price targets for Chemed's stock. Their CHE share price forecasts range from $545.00 to $545.00. On average, they anticipate the company's share price to reach $545.00 in the next year. This suggests a possible upside of 9.2% from the stock's current price.
View analysts price targets for CHE or view top-rated stocks among Wall Street analysts.

Chemed's stock was trading at $510.43 at the beginning of the year. Since then, CHE shares have decreased by 2.3% and is now trading at $498.93.
View the best growth stocks for 2023 here.

Chemed saw a decrease in short interest in January. As of January 15th, there was short interest totaling 287,400 shares, a decrease of 15.7% from the December 31st total of 341,000 shares. Based on an average trading volume of 82,300 shares, the short-interest ratio is currently 3.5 days. Approximately 2.0% of the company's shares are sold short.
View Chemed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CHE earnings forecast.

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Thursday, October, 28th. The company reported $5.06 earnings per share for the quarter, beating the consensus estimate of $4.49 by $0.57. The firm earned $538.67 million during the quarter, compared to the consensus estimate of $531.87 million. Chemed had a trailing twelve-month return on equity of 44.29% and a net margin of 12.31%. The firm's revenue was up 2.0% on a year-over-year basis. During the same period last year, the company posted $4.86 earnings per share.

Chemed declared a quarterly dividend on Friday, November 4th. Stockholders of record on Monday, November 14th will be given a dividend of $0.38 per share on Monday, December 5th. This represents a $1.52 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Thursday, November 10th.
Read our dividend analysis for CHE.

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.30%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

Chemed issued an update on its FY 2022 earnings guidance on Monday, November, 7th. The company provided EPS guidance of $19.60-$19.70 for the period, compared to the consensus EPS estimate of $19.49. The company issued revenue guidance of -.

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed's stock is owned by many different retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.30%), Copeland Capital Management LLC (1.06%), Riverbridge Partners LLC (0.68%), Natixis Advisors L.P. (0.36%), Trinity Street Asset Management LLP (0.20%) and Fenimore Asset Management Inc. (0.18%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CHE stock can currently be purchased for approximately $498.93.

Chemed (NYSE:CHE) has a market capitalization of $7.42 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.21 on an earnings per share basis.

The company employs 14,137 workers across the globe.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.